Literature DB >> 26971996

NLRX1 Acts as an Epithelial-Intrinsic Tumor Suppressor through the Modulation of TNF-Mediated Proliferation.

Ivan Tattoli1, Samuel A Killackey2, Elisabeth G Foerster3, Raphael Molinaro2, Charles Maisonneuve3, Muhammed A Rahman1, Shawn Winer4, Daniel A Winer4, Catherine J Streutker5, Dana J Philpott3, Stephen E Girardin6.   

Abstract

The mitochondrial Nod-like receptor protein NLRX1 protects against colorectal tumorigenesis through mechanisms that remain unclear. Using mice with an intestinal epithelial cells (IEC)-specific deletion of Nlrx1, we find that NLRX1 provides an IEC-intrinsic protection against colitis-associated carcinogenesis in the colon. These Nlrx1 mutant mice have increased expression of Tnf, Egf, and Tgfb1, three factors essential for wound healing, as well as increased epithelial proliferation during the epithelial regeneration phase following injury triggered by dextran sodium sulfate. In primary intestinal organoids lacking Nlrx1, stimulation with TNF resulted in exacerbated proliferation and expression of the intestinal stem cell markers Olfm4 and Myb. This hyper-proliferation response was associated with increased activation of Akt and NF-κB pathways in response to TNF stimulation. Together, these results identify NLRX1 as a suppressor of colonic tumorigenesis that acts by controlling epithelial proliferation in the intestine during the regeneration phase following mucosal injury.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26971996     DOI: 10.1016/j.celrep.2016.02.065

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  21 in total

1.  NLRX1 Regulates Effector and Metabolic Functions of CD4+ T Cells.

Authors:  Andrew Leber; Raquel Hontecillas; Nuria Tubau-Juni; Victoria Zoccoli-Rodriguez; Matthew Hulver; Ryan McMillan; Kristin Eden; Irving C Allen; Josep Bassaganya-Riera
Journal:  J Immunol       Date:  2017-02-03       Impact factor: 5.422

2.  NLRX1 Mediates MAVS Degradation To Attenuate the Hepatitis C Virus-Induced Innate Immune Response through PCBP2.

Authors:  Yuwen Qin; Binbin Xue; Chunyan Liu; Xiaohong Wang; Renyun Tian; Qinya Xie; Mengmeng Guo; Guangdi Li; Darong Yang; Haizhen Zhu
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

3.  Trace levels of peptidoglycan in serum underlie the NOD-dependent cytokine response to endoplasmic reticulum stress.

Authors:  Raphael Molinaro; Tapas Mukherjee; Robert Flick; Dana J Philpott; Stephen E Girardin
Journal:  J Biol Chem       Date:  2019-04-17       Impact factor: 5.157

Review 4.  Immunometabolic rewiring of tubular epithelial cells in kidney disease.

Authors:  Sanne van der Rijt; Jaklien C Leemans; Sandrine Florquin; Riekelt H Houtkooper; Alessandra Tammaro
Journal:  Nat Rev Nephrol       Date:  2022-07-07       Impact factor: 42.439

5.  NLRX1 modulates differentially NLRP3 inflammasome activation and NF-κB signaling during Fusobacterium nucleatum infection.

Authors:  Shu-Chen Hung; Pei-Rong Huang; Cássio Luiz Coutinho Almeida-da-Silva; Kalina R Atanasova; Ozlem Yilmaz; David M Ojcius
Journal:  Microbes Infect       Date:  2017-10-09       Impact factor: 2.700

Review 6.  NLR in eXile: Emerging roles of NLRX1 in immunity and human disease.

Authors:  Robert J Pickering; Lee M Booty
Journal:  Immunology       Date:  2020-12-28       Impact factor: 7.397

7.  The Circadian Clock Gene BMAL1 Coordinates Intestinal Regeneration.

Authors:  Kyle Stokes; Abrial Cooke; Hanna Chang; David R Weaver; David T Breault; Phillip Karpowicz
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-04-05

8.  NLRX1 suppresses tumorigenesis and attenuates histiocytic sarcoma through the negative regulation of NF-κB signaling.

Authors:  Sheryl Coutermarsh-Ott; Alysha Simmons; Vittoria Capria; Tanya LeRoith; Justin E Wilson; Bettina Heid; Casandra W Philipson; Qizhi Qin; Raquel Hontecillas-Magarzo; Josep Bassaganya-Riera; Jenny P-Y Ting; Nikolaos Dervisis; Irving C Allen
Journal:  Oncotarget       Date:  2016-05-31

9.  NLRX1 Modulates Immunometabolic Mechanisms Controlling the Host-Gut Microbiota Interactions during Inflammatory Bowel Disease.

Authors:  Andrew Leber; Raquel Hontecillas; Nuria Tubau-Juni; Victoria Zoccoli-Rodriguez; Vida Abedi; Josep Bassaganya-Riera
Journal:  Front Immunol       Date:  2018-02-26       Impact factor: 7.561

10.  NOD-like receptor X1 functions as a tumor suppressor by inhibiting epithelial-mesenchymal transition and inducing aging in hepatocellular carcinoma cells.

Authors:  Bo Hu; Guang-Yu Ding; Pei-Yao Fu; Xiao-Dong Zhu; Yuan Ji; Guo-Ming Shi; Ying-Hao Shen; Jia-Bin Cai; Zhen Yang; Jian Zhou; Jia Fan; Hui-Chuan Sun; Ming Kuang; Cheng Huang
Journal:  J Hematol Oncol       Date:  2018-02-26       Impact factor: 17.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.